We test this hypothesis using the xCell-gene-signature-based method to infer CD8 T cell abundance in the tumor of large cohorts with publicly available data—The Cancer Genome Atlas (TCGA), Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), and multiple Gene Expression Omnibus (GEO) cohorts. This evidence concerns the gene CD8A and breast cancer.